Biotricity, Inc. is a medical technology company, which engages in biometric data monitoring solutions. The company is headquartered in Redwood City, California and currently employs 46 full-time employees. The company went IPO on 2015-10-26. The firm developed its Bioflux COM technology, comprised of a monitoring device and software components. Its Bioflux and Biocore Pro are integrated electrocardiogram (ECG) device and software solutions for the COM market. The Biocore ECG reporting software allows doctors and labs to view a patient’s ECG data for monitoring and diagnostic purposes. The Bioflux and Biocore Pro platform has a built-in cellular chipset and a real-time embedded operating system which allows its technology to be utilized as an Internet of Things (IoT) platform. The firm has developed several technologies, including Bioheart, Biocare, and Biokit. Biokit is a remote patient monitoring kit that combines a blood pressure cuff, pulse oximeter and a digital thermometer into the Biocare platform to support the collection of additional biometrics for those patients with multiple conditions.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
09/30/2025
06/30/2025
03/31/2025
12/31/2024
Revenue
15
3
3
3
3
3
Revenue Growth (YoY)
15%
0%
0%
0%
0%
50%
Cost of Revenue
2
0
0
0
0
0
Gross Profit
12
3
3
3
2
2
Selling, General & Admin
9
2
2
2
3
2
Research & Development
2
0
0
0
0
0
Operating Expenses
12
2
2
2
3
2
Other Non Operating Income (Expenses)
0
0
0
0
0
0
Pretax Income
-4
0
0
0
-1
-1
Income Tax Expense
--
--
--
0
0
0
Net Income
-4
-1
0
0
-2
-1
Net Income Growth
-71%
0%
-100%
-100%
-50%
-67%
Shares Outstanding (Diluted)
27.59
27.59
26.76
26.28
26.35
24.23
Shares Change (YoY)
14%
14%
19%
86%
179%
170%
EPS (Diluted)
-0.17
-0.04
-0.02
-0.02
-0.07
-0.05
EPS Growth
-70%
-24%
-61%
-94%
-84%
-84%
Free Cash Flow
-1
0
0
0
0
0
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
80%
100%
100%
100%
66.66%
66.66%
Operating Margin
0%
0%
0%
0%
0%
0%
Profit Margin
-26.66%
-33.33%
0%
0%
-66.66%
-33.33%
Free Cash Flow Margin
-6.66%
0%
0%
0%
0%
0%
EBITDA
0
0
0
0
0
0
EBITDA Margin
0%
0%
0%
0%
0%
0%
D&A For EBITDA
0
0
0
0
0
0
EBIT
0
0
0
0
0
0
EBIT Margin
0%
0%
0%
0%
0%
0%
Effective Tax Rate
--
--
--
0%
0%
0%
Follow-Up Questions
What are Biotricity Inc's key financial statements?
According to the latest financial statement (Form-10K), Biotricity Inc has a total asset of $0, Net loss of $0
What are the key financial ratios for BTCY?
Biotricity Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is Biotricity Inc's revenue broken down by segment or geography?
Biotricity Inc largest revenue segment is Technology Fees, at a revenue of 12,591,036 in the most earnings release.For geography, United States is the primary market for Biotricity Inc, at a revenue of 13,790,294.
Is Biotricity Inc profitable?
no, according to the latest financial statements, Biotricity Inc has a net loss of $0
Does Biotricity Inc have any liabilities?
no, Biotricity Inc has liability of 0
How many outstanding shares for Biotricity Inc?
Biotricity Inc has a total outstanding shares of 0